Vanda Pharmaceuticals Inc.
VNDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $70 | $81 | $112 | $102 |
| Short-Term Investments | $224 | $245 | $229 | $272 |
| Receivables | $51 | $45 | $45 | $47 |
| Inventory | $2 | $2 | $2 | $2 |
| Other Curr. Assets | $21 | $22 | $20 | $15 |
| Total Curr. Assets | $367 | $395 | $408 | $439 |
| Property Plant & Equip (Net) | $12 | $12 | $12 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $109 | $111 | $112 | $114 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $103 | $97 | $89 | $81 |
| Other NC Assets | $10 | $10 | $10 | $9 |
| Total NC Assets | $234 | $230 | $224 | $217 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $601 | $625 | $632 | $656 |
| Liabilities | – | – | – | – |
| Payables | $0 | $2 | $6 | $3 |
| Short-Term Debt | $0 | $5 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $118 | $115 | $94 | $92 |
| Total Curr. Liab. | $118 | $121 | $104 | $100 |
| LT Debt | $6 | $7 | $7 | $8 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $11 | $10 | $9 | $10 |
| Total NC Liab. | $17 | $17 | $17 | $18 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $12 | $12 | $12 |
| Total Liabilities | $135 | $138 | $121 | $118 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$254 | -$231 | -$204 | -$174 |
| AOCI | $1 | $0 | $0 | $0 |
| Other Equity | $719 | $717 | $715 | $713 |
| Total Equity | $466 | $486 | $511 | $539 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $601 | $625 | $632 | $656 |
| Net Debt | -$64 | -$69 | -$100 | -$90 |